Select the cell(s) where you want the text to appear vertically. Go to the Home tab in the top ribbon. In the Alignment group, click the Orientation drop-down arrow. Choose Vertical Text from the list ...

Writing a check can be done by filling out six lines on the check. There are also alternatives to sending a check. Many, or all, of the products featured on this page are from our advertising partners ...

Abbott is acquiring Exact Sciences for $23 billion, the global healthcare leader announced on Thursday. Exact Sciences shareholders will receive $105 per common share, totaling approximately $21 ...

Abbott Laboratories could be looking to acquire Exact Sciences, according to a report from Bloomberg, citing people close to the deal. News of the rumored deal caused Madison, WI-based Exact Sciences ...

Abbott to buy Exact Sciences in $23 billion deal Exact's flagship colorectal cancer test to join Abbott's portfolio Abbott eyes international expansion for Exact's tests Aims for broad reimbursement ...

"Smartphones do their best to block scam links, so attackers use tricks to make their links clickable," said Joshua McKenty, CEO of Polyguard.ai, a cybersecurity company that helps businesses protect ...

Abbott announced on Thursday, Nov. 20 it plans to buy Exact Sciences, a Madison-based maker of cancer screening and diagnostic tests, in a deal valued at an estimated $23 billion, including debt. The ...

Subscribe to BizTimes Daily – Local news about the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin. Madison-based Exact Sciences, a maker and provider of cancer ...

MADISON (WKOW) -- Abbott announced it will acquire Exact Sciences for an approximate enterprise value of $23 billion. Exact Sciences, a Madison-based company, is known for several products that focus ...

Acquisition adds a new growth vertical to Abbott (ABT)'s already high single-digit growth profile, gaining leadership in the fast-growing $60 billion U.S. cancer screening and precision oncology ...

In January, Exact Sciences CEO Kevin Conroy told us that 2025 was shaping up to be a transformative year for the diagnostics company. Three cancer test launches, multiple study readouts and one $23 ...